NASDAQ NMS - GLOBAL MARKET · DARE
-1.64% · -$0.0333 · Vol 95.7K
Dare Bioscience Inc

Dare Bioscience Inc

Pharmaceuticals
$2.00
+ Add to watchlist
Card

Veridion Score

Loading
Score loading…
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
Sovereign

Why is DARE moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Dare Bioscience Inc
PHARMACEUTICAL PREPARATIONS
Founded
—
Listed
2014
Employees
24
HQ
US

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Company website →
Key statistics

Real vendor fields plus Veridion-computed history. Missing fields stay blank.

Open
$2.03
Day high
$2.10
Day low
$1.98
Previous close
$2.03
52W high
$2.02
-1.15% from high
52W low
$2.00
0% of range
Market cap
$30.4M
P/E
—
EPS
—
Dividend yield
—
Beta
—
Shares out
15M
Float
—
Volume
95.7K
Avg volume
—
VWAP
$2.03
Next earnings
—
Price history computed in-house
1W
-0.17%
1M
-0.17%
3M
-0.17%
1Y
-0.17%
YTD
-0.17%
SMA 50 $2.01 · below
SMA 200 $2.01 · below
52W position 0%
Veridion warehouse edge

Warehouse intelligence for DARE.

Veridion Score
46
0: 101: 482: 743: —4: —5: —
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
—
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
SEC Form 4 ledger

DARE insider activity

Dare Bioscience Inc

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
$0
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: $0 across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for DARE.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Loading PTR filings…
Federal contracts

DARE contract awards, year to date.

Public federal awards linked to this ticker.

—
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for DARE in this window.
Lobbying spend

DARE lobbying filings, year to date.

Registered lobbying filings matched to Dare Bioscience Inc.

—
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for DARE in this window.
Latest news · DARE
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Sovereign unlock shows live analyst consensus for DARE.
Options
Sovereign unlock shows live options positioning for DARE.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.